Your Feed

Filter by
See content from
Back to the latest
Avatar
XimenaG • Admin
Multiple Myeloma Discussion • March 3
Run Global Marathons to Fund Research
We’re excited to share that HealthTree’s marathon program is going global 🌍 Runners can now access guaranteed bibs for major international races, including Sydney, Berlin, and Tokyo, plus limited spots in bucket list races like Honolulu, Valencia, Dublin, and Venice. Every mile supports lifesaving blood cancer research, with 100 percent of funds raised going directly toward finding cures. 🏃‍♂️ Run with HealthTree. 💙 Run with purpose. Do you know someone who loves to run and would want to make a difference? Please tag them, invite them to this post, or share this with a runner who might want to turn their miles into impact. Your connection could help make this possible. 👉 Learn more and run for your bib here: https://healthtree.org/blood-cancer/marathon-program?utm_source=social_media&utm_medium=meta&utm_campaign=socialmediaorganic&utm_content=general
Thumbnail for What are the latest research advancements and future directions in managing graft versus host disease in acute myeloid leukemia patients?
Playlist: Graft vs Host Disease

What are the latest research advancements and future directions in managing graft versus host disease in acute myeloid leukemia patients?

Video details & playlist
Avatar
Iliana • Admin
Multiple Myeloma Discussion • March 1
Share Your Story for Myeloma Innovation
AI-generated title
Every journey is unique, and so is every patient. At HealthTree, Innovation In Myeloma means more than scientific breakthroughs. It’s new ways to understand the disease, new ways to connect patients with knowledge, research, and community, and new ways to turn lived experience into progress. This March, take one step to make an impact. Learn more here: https://htree.org/myelomaawarenessmonth2026 Share your story, join the conversation, and invite others to participate. Innovation in Myeloma Starts With You. 💜
Avatar
XimenaG • Admin
Multiple Myeloma Discussion • February 27
Ask an Expert: Live Q&A on Myeloma Innovations
💜 Ask the Expert: Innovations in Multiple Myeloma Join us during Multiple Myeloma Awareness Month for a live Q&A webinar with DR. Craig Cole, a leading expert in multiple myeloma care. This interactive session is focused entirely on patient and caregiver questions, covering the latest innovations in myeloma treatment, evolving care strategies, and what these advances mean for people living with myeloma today. 🗓 March 6, 2026 ⏰ 3:00 to 4:00 PM EST Can’t attend live? All registered participants will receive the recording. 👉 Register here: https://healthtree.org/myeloma/community/events/mar26-ask-your-questions-dr-cole?utm_source=social_media&utm_medium=meta&utm_campaign=mmam2026&utm_content=general
Avatar
DianaSoto • Admin
Chronic Myelomonocytic Leukemia Discussion • February 26
testing again :)
testing again :)
Avatar
TimJohnson
Multiple Myeloma Discussion • February 26
Lambda Light Chains spiking??
Good morning MM Warriors and Heroes (caregivers). I've been on maintenance of Dara once a month and Pomalyst 1mg 28/28 since Halloween and have been bubbling along at a low simmer. All my numbers move up or down slightly every month but all within or very near normal range. NO CRAB or other issues or side effects. Until this month's light chains result. My lambda light chains have been hovering around 9mg/l +/- 2mg/l since early last year. This week's result more than doubled from 11.56 mg/l last month to 24.3 mg/l this month. Kappas have been behaving themselves in the 6mg/l range - all within "normal" ranges. We're still waiting on the SPEP result (it's been a steady 0.9 since September) to see if anything changed drastically there. I see the local tomorrow for my regular visit and treatment and hopefully get more information and context. The "It's still within normal range" email from the nurse wasn't all that reassuring. Has anyone else seen or experienced radical jumps in their light chains when nothing else (treatment or results) stays the same? Thanks.